| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
787,100,000 |
| Market
Cap: |
85.20(B) |
| Last
Volume: |
191,226,646 |
Avg
Vol: |
86,779,483 |
| 52
Week Range: |
$108.24 - $108.24 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
NASDAQ-100 |
| |
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Loughlin James J |
Director |
– • – |
2009-05-06 |
5 |
GD |
$0.00 |
$0 |
D/D |
600 |
1,000 |
|
- |
|
| Loughlin James J |
Director |
– • – |
2009-05-06 |
4 |
B |
$39.57 |
$23,742 |
D/D |
600 |
1,600 |
2.39 |
- |
|
| Kaplan Gilla Phd |
Director |
– • – |
2009-03-12 |
4 |
S |
$45.86 |
$917,232 |
D/D |
(20,000) |
0 |
|
- |
|
| Kaplan Gilla Phd |
Director |
– • – |
2009-03-12 |
4 |
OE |
$7.70 |
$154,050 |
D/D |
20,000 |
20,000 |
|
- |
|
| Robb Walter L |
Director |
– • – |
2009-02-05 |
4 |
S |
$53.08 |
$2,786,921 |
D/D |
(52,500) |
12,648 |
|
- |
|
| Robb Walter L |
Director |
– • – |
2009-02-05 |
4 |
OE |
$10.97 |
$693,488 |
D/D |
52,500 |
65,148 |
|
- |
|
| Drake Rodman L |
Director |
– • – |
2008-12-02 |
4 |
S |
$49.75 |
$39,553 |
D/D |
(795) |
2,705 |
|
- |
|
| Robb Walter L |
Director |
– • – |
2008-11-07 |
4 |
S |
$62.01 |
$1,860,303 |
D/D |
(30,000) |
12,648 |
|
- |
|
| Robb Walter L |
Director |
– • – |
2008-11-07 |
4 |
OE |
$11.21 |
$337,275 |
D/D |
30,000 |
42,648 |
|
- |
|
| Hugin Robert J |
President and COO |
• • – |
2008-11-04 |
4 |
AS |
$0.00 |
$0 |
I/I |
(0) |
17,043 |
|
- |
|
| Hugin Robert J |
President and COO |
• • – |
2008-11-04 |
4 |
AS |
$64.27 |
$18,727,258 |
D/D |
(291,366) |
415,214 |
|
- |
|
| Gryska David W |
Chief Financial Officer |
• – – |
2008-11-03 |
4 |
S |
$64.50 |
$1,500,528 |
D/D |
(23,264) |
0 |
|
- |
|
| Gryska David W |
Chief Financial Officer |
• – – |
2008-11-03 |
4 |
OE |
$57.58 |
$1,339,541 |
D/D |
23,264 |
23,264 |
|
- |
|
| Burton Graham |
Sr VP, GRA & Pharmacovigilance |
• – – |
2008-11-03 |
4 |
D |
$65.23 |
$2,879,448 |
D/D |
(44,143) |
91,428 |
|
- |
|
| Burton Graham |
Sr VP, GRA & Pharmacovigilance |
• – – |
2008-11-03 |
4 |
OE |
$7.78 |
$696,457 |
D/D |
82,884 |
99,762 |
|
- |
|
| Hugin Robert J |
President and COO |
• • – |
2008-11-03 |
4 |
D |
$65.23 |
$516,100 |
D/D |
(7,912) |
706,580 |
|
- |
|
| Hugin Robert J |
President and COO |
• • – |
2008-11-03 |
4 |
OE |
$1.30 |
$516,152 |
D/D |
396,400 |
714,492 |
|
- |
|
| Barer Sol J |
Chief Executive Officer |
• • – |
2008-10-30 |
4 |
S |
$63.38 |
$15,869,191 |
D/D |
(250,388) |
543,884 |
|
- |
|
| Hugin Robert J |
President & COO |
• • – |
2008-09-29 |
4 |
OE |
$12.59 |
$299,925 |
D/D |
22,800 |
318,092 |
|
- |
|
| Barer Sol J |
Chief Executive Officer |
• • – |
2008-09-29 |
4 |
OE |
$12.59 |
$199,947 |
D/D |
15,784 |
794,272 |
|
- |
|
| Hugin Robert J |
Pres & Chief Operating Officer |
• • – |
2008-09-03 |
4 |
AS |
$68.38 |
$12,576,897 |
D/D |
(183,933) |
355,292 |
|
- |
|
| Hugin Robert J |
Pres & Chief Operating Officer |
• • – |
2008-09-02 |
4 |
D |
$68.44 |
$325,501 |
D/D |
(4,756) |
539,225 |
|
- |
|
| Hugin Robert J |
Pres & Chief Operating Officer |
• • – |
2008-09-02 |
4 |
OE |
$1.30 |
$325,525 |
D/D |
250,000 |
543,981 |
|
- |
|
| Hugin Robert J |
President and COO |
• • – |
2008-08-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
60,000 |
415,214 |
|
- |
|
| Hugin Robert J |
President and COO |
• • – |
2008-08-04 |
4 |
AS |
$73.24 |
$21,585,766 |
D/D |
(294,716) |
293,981 |
|
- |
|
956 Records found
|
|
Page 30 of 39 |
|
|
